Evidence map›Paper›PMID 37962922›Full record

ArticleGlycobiology2024

Reusable glycan microarrays using a microwave assisted wet-erase (MAWE) process.

Akul Y Mehta, Catherine A Tilton, Lukas Muerner, Stephan von Gunten, Jamie Heimburg-Molinaro, Richard D Cummings

Abstract read
In one paragraph

Article in Glycobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Akul Y MehtaDepartment of Surgery, Beth Israel Deaconess Medical Center, National Center for Functional Glycomics, Harvard Medical School, 3 Blackfan Circle, Center for Life Sciences, Boston, MA 02115, United States.
Catherine A TiltonDepartment of Surgery, Beth Israel Deaconess Medical Center, National Center for Functional Glycomics, Harvard Medical School, 3 Blackfan Circle, Center for Life Sciences, Boston, MA 02115, United States.
Lukas MuernerDepartment of Surgery, Beth Israel Deaconess Medical Center, National Center for Functional Glycomics, Harvard Medical School, 3 Blackfan Circle, Center for Life Sciences, Boston, MA 02115, United States.
Stephan von GuntenInstitute of Pharmacology, University of Bern, Inselspital, INO-F, Bern 3010, Switzerland.
Jamie Heimburg-MolinaroDepartment of Surgery, Beth Israel Deaconess Medical Center, National Center for Functional Glycomics, Harvard Medical School, 3 Blackfan Circle, Center for Life Sciences, Boston, MA 02115, United States.
Richard D CummingsDepartment of Surgery, Beth Israel Deaconess Medical Center, National Center for Functional Glycomics, Harvard Medical School, 3 Blackfan Circle, Center for Life Sciences, Boston, MA 02115, United States.

Funding

Overall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9M
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)R24GM137763 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI RICHARD D CUMMINGS · 2020 to 2026
$5.8M
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey SystemR01GM140201 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CUMMINGS, RICHARD D · 2021 to 2023
$1.5M
NIGMS NIH HHS P41 GM103694NIGMS NIH HHS R01 GM140201NIGMS NIH HHS R24 GM137763NIH HHS P41GM103694Swiss National Science Foundation 310030_184757
6 · The paper itself

Abstract

Modern studies on binding of proteins to glycans commonly involve the use of synthetic glycans and their derivatives in which a small amount of the material is covalently printed onto a functionalized slide in a glycan microarray format. While incredibly useful to explore binding interactions with many types of samples, the common techniques involve drying the slides, which leads to irreversible association of the protein to the spots on slides to which they bound, thus limiting a microarray to a single use. We have developed a new technique which we term Microwave Assisted Wet-Erase (MAWE) glycan microarrays. In this approach we image the slides under wet conditions to acquire the data, after which the slides are cleaned of binding proteins by treatment with a denaturing SDS solution along with microwave treatment. Slides cleaned in this way can be reused multiple times, and an example here shows the reuse of a single array 15 times. We also demonstrate that this method can be used for a single-array per slide or multi-array per slide platforms. Importantly, the results obtained using this technique for a variety of lectins sequentially applied to a single array, are concordant to those obtained via the classical dry approaches on multiple slides. We also demonstrate that MAWE can be used for different types of samples, such as serum for antibody binding, and whole cells, such as yeast. This technique will greatly conserve precious glycans and prolong the use of existing and new glycan microarrays.

Indexed as

Carrier ProteinsMicrowavesLectinsMicroarray AnalysisPolysaccharidesCarrier ProteinsLectinsPolysaccharidesglycan binding proteinsglycan microarraysmicrowavereusable microarrays

Identifiers

PMID37962922
PMCPMC10969520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.